I tried to fill in the blanks but got lost among the facts
Most stocks don't have on board the likes of Dr Peter Corr
Navigant wouldn't waste their time with 90% of ASX stocks
Unlike many stocks there's all that debt we don't have
A unique, effective, economical device, in a class of its own without direct competition, with significant benefit to half the global population, supported by professionals, meeting a massive unmet need, in the booming e-health sector
But in contrast to all the other asx stocks this is an absolute dud?
Following your logic of sp, sales & mc I should flee to the safety of blue chips; or punt on a driller or digger with 1/10 chance, or gamble on clinical trials, or put my money on a crypto with no vision of outcome
I'll play this game my way, with my perception of risk/reward
The sp/mc, which fortunately for me reflects in part a lack of hype which is attached to many currently trendy stocks, is an opportunity; the lack of sales & more importantly a deal so far makes this a good time to get in. The major positives mentioned are free; the sp is for our other product
(imo, dyor)
I suspect you're at the end of the line of .04 buyers, or a disgruntled former holder
Regardless, your downramping is just sad The reason I don't report your lack of respect for hotcopper or fellow punters is so all can see your character.
